Answers are grounded in this paper and cite their sources.
Preclinical engineering study demonstrates collision-free robotic needle steering in liver phantom models, highlighting the potential for targeting deep-seated lesions.
This paper presents the design, development and evaluation of a novel robotic platform for endoscopic ultrasound-guided fine-needle biopsy of liver lesions. The system combines a four degrees-of-freedom (DoF) two-segment tendon-driven continuum robot (TDCR) endoscope with a two DoF superelastic nickel–titanium bevel-tip steerable needle. Needle path planning is achieved using NeedleNav, a soft actor–critic (SAC) deep reinforcement learning (DRL) model that generates collision-free trajectories to deep-seated lesions. This represents one of the first integrated systems combining a TDCR, steerable needle and DRL-based navigation, and the first application of a SAC to liver lesion targeting. Evaluation of the TDCR through tip tracking of circular, diamond-shaped and arc trajectories demonstrated a mean absolute error (MAE) of 13.19 mm. NeedleNav converged to obstacle avoidance trajectories in ~ ∼ 2500 training episodes. Needle curvature was augmented by hand-fabricating notches on its distal section. Two needles with a 3-cm and 8-cm notched section were evaluated in a gelatine liver phantom, achieving an MAE of 21.78 mm and 14.86 mm, respectively, for obstacle avoidance trajectories. The system demonstrated observable path deflection compared to obstacle-free trajectories for the same targets. Together, these findings suggest the feasibility of our proposed solution, expanding the reach of endoscopic needle interventions to deep-seated lesions in the right lobe.
No takes yet. Share an insight, caveat, or question.
Khanna et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: